Theravance Biopharma (TBPH) Capital Expenditures (QoQ) (2013 - 2024)
Theravance Biopharma (TBPH) Capital Expenditures (QoQ) (2013 - 2024) Analysis & Trends
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
| 1 |
Alterity Therapeutics |
814,307.08 Bn |
814,307.05 Bn |
- |
| 2 |
Belite Bio |
55,320.00 Bn |
55,320.00 Bn |
- |
| 3 |
Quantum Biopharma |
17,149.72 Bn |
17,149.72 Bn |
- |
| 4 |
Legend Biotech |
3,590.00 Bn |
3,589.71 Bn |
242.10 Mn |
| 5 |
Akari Therapeutics |
1,650.72 Bn |
1,650.72 Bn |
- |
| 6 |
Evaxion A |
1,522.09 Bn |
1,522.07 Bn |
- |
| 7 |
Psyence Biomedical |
229.39 Bn |
229.38 Bn |
- |
| 8 |
Vertex Pharmaceuticals |
113.09 Bn |
105.85 Bn |
2.59 Bn |
| 9 |
Abivax |
90.15 Bn |
90.15 Bn |
- |
| 10 |
Theravance Biopharma |
850.21 Mn |
455.54 Mn |
- |
| Date | Value |
|---|
| Dec 31, 2024 |
1,166.67% |
| Sep 30, 2024 |
-58.33% |
| Jun 30, 2024 |
-60.44% |
| Mar 31, 2024 |
-86.56% |
| Dec 31, 2023 |
3,123.81% |
| Sep 30, 2023 |
-97.54% |
| Jun 30, 2023 |
-9.17% |
| Mar 31, 2023 |
252.63% |
| Dec 31, 2022 |
566.67% |
| Sep 30, 2022 |
-150.44% |
| Jun 30, 2022 |
-54.80% |
| Mar 31, 2022 |
-43.69% |
| Dec 31, 2021 |
-57.27% |
| Sep 30, 2021 |
566.03% |
| Jun 30, 2021 |
-91.17% |
| Mar 31, 2021 |
42.04% |
| Dec 31, 2020 |
-39.32% |
| Sep 30, 2020 |
-13.43% |
| Jun 30, 2020 |
148.22% |
| Mar 31, 2020 |
-26.78% |
